Addus HomeCare Co. (NASDAQ:ADUS) Receives Consensus Rating of "Buy" from Brokerages

Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report) has been given an average recommendation of "Buy" by the ten ratings firms that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, seven have issued a buy rating and two have issued a strong buy rating on the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $132.78.

Several research analysts have commented on the stock. JMP Securities reissued a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a report on Thursday, April 10th. Macquarie reissued an "outperform" rating and set a $129.00 price target on shares of Addus HomeCare in a research note on Thursday, February 27th. Oppenheimer lifted their price objective on Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Citizens Jmp upgraded Addus HomeCare to a "strong-buy" rating in a research report on Monday, December 16th. Finally, StockNews.com cut shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research report on Wednesday, February 26th.

Addus HomeCare Trading Down 2.3 %

Shares of ADUS traded down $2.33 during trading hours on Friday, reaching $99.84. 81,838 shares of the stock traded hands, compared to its average volume of 218,568. Addus HomeCare has a 52-week low of $87.88 and a 52-week high of $136.72. The company has a market cap of $1.81 billion, a P/E ratio of 22.85, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93. The company's 50-day moving average price is $100.73 and its two-hundred day moving average price is $117.77.

Remove Ads

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $297.14 million during the quarter, compared to the consensus estimate of $291.04 million. On average, research analysts forecast that Addus HomeCare will post 4.59 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP increased its position in shares of Addus HomeCare by 1.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 692,713 shares of the company's stock worth $86,833,000 after acquiring an additional 10,434 shares during the period. State Street Corp increased its holdings in Addus HomeCare by 4.4% during the 3rd quarter. State Street Corp now owns 663,610 shares of the company's stock worth $88,280,000 after purchasing an additional 27,990 shares during the period. Principal Financial Group Inc. raised its position in Addus HomeCare by 17.5% during the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company's stock valued at $67,293,000 after purchasing an additional 75,409 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Addus HomeCare by 7.1% in the 3rd quarter. Geode Capital Management LLC now owns 423,934 shares of the company's stock worth $56,406,000 after buying an additional 28,284 shares during the period. Finally, Capital Research Global Investors bought a new position in shares of Addus HomeCare during the 4th quarter worth $51,149,000. Hedge funds and other institutional investors own 95.35% of the company's stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.